BFSG LLC’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.41K Hold
18
﹤0.01% 660
2026
Q1
$3.55K Hold
18
﹤0.01% 645
2025
Q4
$3.31K Hold
18
﹤0.01% 620
2025
Q3
$2.76K Hold
18
﹤0.01% 628
2025
Q2
$2.52K Hold
18
﹤0.01% 598
2025
Q1
$2.65K Hold
18
﹤0.01% 591
2024
Q4
$2.36K Hold
18
﹤0.01% 603
2024
Q3
$2.81K Hold
18
﹤0.01% 574
2024
Q2
$2.81K Hold
18
﹤0.01% 560
2024
Q1
$2.44K Hold
18
﹤0.01% 584
2023
Q4
$2.42K Buy
+18
New +$2.34K ﹤0.01% 537

Other funds holding AZN

BFSG LLC's AZN Position: Q2 2026 in Review

BFSG LLC held its AstraZeneca (AZN) position steady in Q2 2026 at 18 shares worth $3.41K. The position accounts for ﹤0.01% of the portfolio, ranked #660.

BFSG LLC first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.55K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • BFSG LLC held 18 shares of AstraZeneca worth $3.41K as of Q2 2026.
  • BFSG LLC left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up ﹤0.01% of BFSG LLC's portfolio in Q2 2026, its #660 holding.
  • BFSG LLC first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
  • BFSG LLC's AstraZeneca position peaked at $3.55K in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.